Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Hydroxyurea × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 8 Head and Neck Neoplasms 7 Salivary Gland Neoplasms 2 Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Laryngeal Diseases 1 Esthesioneuroblastoma, Olfactory 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

pembrolizumab 21 Cisplatin 20 Magnetic Resonance Spectroscopy 17 Specimen Handling 15 Radiotherapy, Intensity-Modulated 11 Carboplatin 10 Cetuximab 9 Platinum 8 Paclitaxel 8 1,2-diaminocyclohexaneplatinum II citrate 8 Fluorouracil 5 Biopsy 5 Radiotherapy 4 Radiation 4 Docetaxel 4 (225)Ac-DOTA-c(RGDyK) 4 Taxes 3 Pemetrexed 3 Nivolumab 3 reolysin 2 pralsetinib 2 ipatasertib 2 atezolizumab 2 X-Rays 2 Standard of Care 2 Radiotherapy, Image-Guided 2 Radiosurgery 2 Practice Guidelines as Topic 2 Panitumumab 2 Immunoglobulin G 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00468169 2019-10-09

EPIC

University of Chicago

Phase 2 Completed

110 enrolled 14 charts

Carcinoma, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡